Monday, 19 March 2012

Food And Drug Administration-General Anxiety Disorder-Acute Myeloid Leukemia-Teva Pharmaceuticals

Detailed Gene Scan Might Help Guide Leukemia Treatment

WEDNESDAY, March 14 (HealthDay News) -- By analyzing gene mutations in patients with acute myeloid leukemia, researchers were able to more accurately predict which ones had the best chances of going into remission, and which ones would respond well to standard treatments or needed more aggressive treatment. read more..


First Generic Lexapro Approved

WEDNESDAY, March 14 (HealthDay News) -- The Israeli drug maker Teva Pharmaceuticals has gained the first U.S. approval to market generic Lexapro (escitalopram) to treat depression and general anxiety disorder, the U.S. Food and Drug Administration said Wednesday. read more..

No comments:

Post a Comment